◀ Back to MAPK11
ANXA1 — MAPK11
Text-mined interactions from Literome
Castro-Caldas et al., Mediators Inflamm 2003
:
Furthermore, the cAMP antagonist, Rp-8-Br-cAMPS, and the specific p38
MAPK inhibitor, SB203580, effectively
prevented both Dex induced, E2beta induced and dBcAMP induced CREB activation and
ANXA1 synthesis
Kitanaka et al., Biochem Biophys Res Commun 2006
:
Collectively, it is suggested that E-FABP may be a novel negative regulator of IL-12 production in DCs, and this regulation may be exerted via its involvement in the
p38MAPK mediated transcription of
IL-12p35
Yang et al., J Immunol 2009
:
GC-induced GILZ expression and GC inhibition of NF-kappaB activation were restored by expression of
ANXA1 in ANXA1 ( -/- ) cells, and GILZ overexpression in ANXA1 ( -/- ) macrophages
reduced ERK
MAPK phosphorylation and restored sensitivity of cytokine expression and NF-kappaB activation to GC
Reuter et al., PloS one 2012
(Inflammation...) :
These differences in epithelial restitution were TGF-ß independent but Dex
inhibited the
EGF/ERK1/2/MAPK-pathway important for intestinal epithelial wound healing by induction of MKP-1 and
Annexin-1 which was not affected by CpdA or ZK216348
Ayroldi et al., FASEB J 2012
(MAP Kinase Signaling System) :
Some of these interactions involve the GC-mediated up-regulation of proteins that in turn interfere with the
activation of
MAPK , such as glucocorticoid-induced-leucine zipper, MAPK phosphatase-1, and
annexin-1